Joseph Y. Chang, Chief Scientific Officer and Executive Vice President of Product Development at Nu Skin. (Photo provided by Nu Skin)
Nu Skin's revenue in Chinese market has seen rapid growth, said Joseph Y. Chang, Chief Scientific Officer and Executive Vice President of Product Development at Nu Skin, in a recent interview with Xinhuanet.
Our achievements in the Chinese mainland market are very encouraging and it is on top agenda to expand investment in China, he said.
In 2017, Nu Skin's annual revenue in Greater China market reached US$880 million, with about US$720 million coming from mainland market, representing 17.5% growth compared with the previous year.
In the second quarter of 2018, Nu Skin's revenue in Chinese market increased by 43% than the previous year, and its revenue in the first half of the year showed a 37% year-on-year growth, according to Chang.
With innovation at the core of the Group’s growth strategy, Nu skin has improved its product and service quality to meet the increasing consumption demand in China, he said.
To keep its technological edge, Nu Skin has established two R&D centers, one in the U.S., the other in China’s Shanghai, Chang noted.
As a U.S. multinational company that has been investing in China for nearly 20 years, Nu Skin has always advocated strengthening bilateral cooperation to jointly promote economic and trade development, he said.
